Cite
HARVARD Citation
Díez‐Campelo, M. et al. (2018). Azacitidine improves outcome in higher‐risk MDS patients with chromosome 7 abnormalities: a retrospective comparison of GESMD and GFM registries. British journal of haematology. pp. 350-359. [Online].